Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for acute pain after abdominoplasty
NCT02820324Phase 3Completed
- Sponsor
- Trevena, Inc.
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oliceridine in acute pain, sponsored by Trevena, Inc.. Started May 2016; status: completed.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02820324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02820324.